Benzinga··Vandana SinghImmunityBio Surges on NCCN Bladder Cancer Guideline Inclusion for Anktiva
ImmunityBio stock rises 2.01% after NCCN includes Anktiva bladder cancer therapy in updated clinical guidelines; FDA resubmission underway.
IBRXbladder cancerAnktiva